Ignacio
Gil Bazo
Researcher to 2022
Institut d'Investigació Biomédica de Bellvitge
Barcelona, EspañaPublications in collaboration with researchers from Institut d'Investigació Biomédica de Bellvitge (2)
2018
-
Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis
The Lancet Respiratory Medicine, Vol. 6, Núm. 10, pp. 771-781
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483